Format

Send to

Choose Destination
See comment in PubMed Commons below
J Clin Densitom. 2007 Jan-Mar;10(1):102-10. Epub 2006 Dec 27.

Role of dual-energy X-ray absorptiometry in the diagnosis and treatment of osteoporosis.

Author information

1
King's College London School of Medicine, London, UK. glen.blake@kcl.ac.uk

Abstract

Dual energy X-ray absorptiometry (DXA) measurements of spine and hip bone mineral density (BMD) (referred to here as central DXA) have an important role as a clinical tool for the evaluation of individuals at risk of osteoporosis, and in helping clinicians give advice to patients about the appropriate use of antifracture treatment. Compared with alternative bone densitometry techniques such quantitative computed tomography (QCT), peripheral DXA (pDXA) and quantitative ultrasound (QUS), central DXA has a number of significant advantages that include a consensus that BMD results can be interpreted using the World Health Organization (WHO) T-score definition of osteoporosis, a proven ability to predict fracture risk, and proven effectiveness at targeting antifracture treatments. This review article discusses the evidence for these and other advantages of central DXA, including its role in the new WHO algorithm for treating patients on the basis of individual fracture risk.

PMID:
17289532
DOI:
10.1016/j.jocd.2006.11.001
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center